or

That brought it close to correction territory, typically defined as a drop of 10% or more from a recent high.

“Vascular dementia is not as well understood in the sense that we do know that it is often resulting from damage to blood vessels in the brain, such as from stroke or also contributed from high blood pressure or diabetes,” said Laura Nisenbaum, executive director of drug development for the Alzheimer’s Drug Discovery Foundation, “but we don’t have established biomarkers that we can use to stage the development.”

About 2.7 million people in the U.S. are thought to have mixed dementia or vascular dementia, which is caused by strokes or mini-strokes that damage blood vessels in the brain.

Novo’s Wegovy is already approved for people with obesity or are overweight, in addition to helping those patients lower the risk of stroke, heart attack and death.

That brought it close to correction territory, typically defined as a drop of 10% or more from a recent high.